Molecular and Cellular Biochemistry

, Volume 374, Issue 1–2, pp 113–123

Knockdown of dishevelled-1 attenuates cyclosporine A-induced apoptosis in H9c2 cardiomyoblast cells

  • Yejing Zhu
  • Jinyu Chi
  • Yue Liu
  • Yihua Sun
  • Yu Fu
  • Xiaohui Zhang
  • Xueliang Ding
  • Xinhua Yin
  • Dechao Zhao


Cyclosporine (CsA) has become a mainstay for immune suppression of organ transplants. It is known that patients receiving CsA manifest increased growth of aggressive cardiotoxicity. We have demonstrated that CsA induces myocardium cell apoptosis in vivo and vitro. Recently, dishevelled-1 (Dvl-1) protein, which is a cytoplasmic mediator of Wnt/β-catenin signaling, was explored in cardiac diseases. However, whether Dvl-1 is involved in CsA-induced apoptosis remains to be determined. The aim of this study was to explore the role of Dvl-1 in CsA-induced apoptosis in H9c2 cardiomyoblast cells and to investigate the role of the Wnt/β-catenin signaling cascade in this progress. H9c2 cells were treated with CsA in dose and time-dependent manners. We found that the appropriate concentrations and time-points of CsA-induced the expression of Dvl-1 and subsequent up-regulation of β-catenin and c-Myc, which is consistent with previously demonstrated concentrations and time-points when H9c2 cells apoptosis occurred. Then, cells were transfected with small interfering RNA (siRNA) against Dvl-1 and stimulated with previously demonstrated concentration of CsA. Dvl-1 down-regulation decreased the apoptotic rate, caspase-3 activity, and the Bax/Bcl-2 ratio in H9c2 cells treated with CsA. Furthermore, knocking down the expression of Dvl-1 partially suppressed the activity of the Wnt/β-catenin pathway. Moreover, we further deleted the downstream member β-catenin by specific siRNA, and found that CsA-induced the Bax/Bcl-2 ratio and the expression of c-Myc, which were attenuated. Our results are the first to unveil this novel aspect of Dvl-1 signaling. In addition, these data provide insight into the pathogenesis and the therapeutic strategies of CsA-induced myocardial injury.


Cyclosporine A Dishevelled-1 Wnt/β-catenin signaling Apoptosis 


  1. 1.
    Laczkovics A, Havel M, Teufelsbauer H, Horvath R, Schreiner W, Wolner E (1987) Cyclosporin-A induced heart failure after orthotopic heart transplantation. Thorac Cardiovasc Surg 35:83–86PubMedCrossRefGoogle Scholar
  2. 2.
    Wongmekiat O, Thamprasert K (2005) Investigating the protective effects of aged garlic extract on cyclosporin-induced nephrotoxicity in rats. Fundam Clin Pharmacol 19:555–562PubMedCrossRefGoogle Scholar
  3. 3.
    Selcoki Y, Uz E, Bayrak R, Sahin S, Kaya A, Uz B, Karanfil A, Ozkara A, Akcay A (2007) The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats. Toxicology 239:53–59PubMedCrossRefGoogle Scholar
  4. 4.
    Rezzani R, Rodella LF, Fraschini F, Gasco MR, Demartini G, Musicanti C, Reiter RJ (2009) Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage. J Pineal Res 46:255–261PubMedCrossRefGoogle Scholar
  5. 5.
    Zhao Y, Hou G, Zhang Y, Chi J, Zhang L, Zou X, Tang J, Liu Y, Fu Y, Yin X (2011) Involvement of the calcium-sensing receptor in cyclosporin A-induced cardiomyocyte apoptosis in rats. Pharmazie 669:68–974Google Scholar
  6. 6.
    Ozkan G, Ulusoy S, Alkanat M, Orem A, Akcan B, Ersoz S, Yulug E, Kaynar K, Al S (2012) Antiapoptotic and antioxidant effects of GSPE in preventing cyclosporine A-induced cardiotoxicity. Ren Fail 34:460–466PubMedCrossRefGoogle Scholar
  7. 7.
    Rezzani R, Rodella LF, Bonomini F, Tengattini S, Bianchi R, Reiter RJ (2006) Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated. J Pineal Res 41:288–295PubMedCrossRefGoogle Scholar
  8. 8.
    Waldmeier PC, Feldtrauer JJ, Qian T, Lemasters JJ (2002) Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol Pharmacol 62:22–29PubMedCrossRefGoogle Scholar
  9. 9.
    Gao C, Chen YG (2010) Dishevelled: the hub of Wnt signaling. Cell Signal 22:717–727PubMedCrossRefGoogle Scholar
  10. 10.
    Wallingford JB, Habas R (2005) The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development 132:4421–4436PubMedCrossRefGoogle Scholar
  11. 11.
    Moon RT, Kohn AD, De Ferrari GV, Kaykas A (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5:691–701PubMedCrossRefGoogle Scholar
  12. 12.
    van Gijn ME, Snel F, Cleutjens JP, Smits JF, Blankesteijn WM (2001) Overexpression of components of the Frizzled-Dishevelled cascade results in apoptotic cell death, mediated by beta-catenin. Exp Cell Res 265:46–53PubMedCrossRefGoogle Scholar
  13. 13.
    Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit MR, Weiss CS, Wolf D, Riffel J, Bauer A, Katus HA, Hardt SE (2010) Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension 55:939–945PubMedCrossRefGoogle Scholar
  14. 14.
    van de Schans VA, van den Borne SW, Strzelecka AE, Janssen BJ, van der Velden JL, Langen RC, Wynshaw-Boris A, Smits JF, Blankesteijn WM (2007) Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy. Hypertension 49:473–480PubMedCrossRefGoogle Scholar
  15. 15.
    Chi J, Zhu Y, Fu Y, Liu Y, Zhang X, Han L, Yin X, Zhao D (2012) Cyclosporin A induces apoptosis in H9c2 cardiomyoblast cells through calcium-sensing receptor-mediated activation of the ERK MAPK and p38 MAPK pathways. Mol Cell Biochem 367:227–236PubMedCrossRefGoogle Scholar
  16. 16.
    Yeh CT, Yao CJ, Yan JL, Chuang SE, Lee LM, Chen CM, Yeh CF, Li CH, Lai GM (2011) Apoptotic Cell Death and Inhibition of Wnt/beta-Catenin Signaling Pathway in Human Colon Cancer Cells by an Active Fraction (HS7) from Taiwanofungus camphoratus. Evidence Based Complement Altern Med 2011:750230Google Scholar
  17. 17.
    Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM (2003) Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22:7218–7221PubMedCrossRefGoogle Scholar
  18. 18.
    Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480PubMedCrossRefGoogle Scholar
  19. 19.
    Sundarraj S, Thangam R, Sreevani V, Kaveri K, Gunasekaran P, Achiraman S, Kannan S (2012) Gamma-Sitosterol from Acacia nilotica L. induces G2/M cell cycle arrest and apoptosis through c-Myc suppression in MCF-7 and A549 cells. J Ethnopharmacol 141(3):803–809PubMedCrossRefGoogle Scholar
  20. 20.
    Jarvinen K, Hotti A, Santos L, Nummela P, Holtta E (2011) Caspase-8, c-FLIP, and caspase-9 in c-Myc-induced apoptosis of fibroblasts. Exp Cell Res 317:2602–2615PubMedCrossRefGoogle Scholar
  21. 21.
    Klaus A, Birchmeier W (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8:387–398PubMedCrossRefGoogle Scholar
  22. 22.
    Tzahor E (2007) Wnt/beta-catenin signaling and cardiogenesis: timing does matter. Dev Cell 13:10–13PubMedCrossRefGoogle Scholar
  23. 23.
    Parmalee NL, Kitajewski J (2008) Wnt signaling in angiogenesis. Curr Drug Targets 9:558–564PubMedCrossRefGoogle Scholar
  24. 24.
    Sharov VG, Todor A, Khanal S, Imai M, Sabbah HN (2007) Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure. J Mol Cell Cardiol 42:150–158PubMedCrossRefGoogle Scholar
  25. 25.
    Florio S, Ciarcia R, Crispino L, Pagnini U, Ruocco A, Kumar C, D’Andrilli G, Russo F (2003) Hydrocortisone has a protective effect on CyclosporinA-induced cardiotoxicity. J Cell Physiol 195:21–26PubMedCrossRefGoogle Scholar
  26. 26.
    Tang J, Wang G, Liu Y, Fu Y, Chi J, Zhu Y, Zhao Y, Yin X (2011) Cyclosporin A induces cardiomyocyte injury through calcium-sensing receptor-mediated calcium overload. Pharmazie 66:52–57PubMedGoogle Scholar
  27. 27.
    Hail N Jr, Carter BZ, Konopleva M, Andreeff M (2006) Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis 11:889–904PubMedCrossRefGoogle Scholar
  28. 28.
    Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O’Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435:677–681PubMedCrossRefGoogle Scholar
  29. 29.
    Gu X, Yao Y, Cheng R, Zhang Y, Dai Z, Wan G, Yang Z, Cai W, Gao G, Yang X (2011) Plasminogen K5 activates mitochondrial apoptosis pathway in endothelial cells by regulating Bak and Bcl-x(L) subcellular distribution. Apoptosis 16:846–855PubMedCrossRefGoogle Scholar
  30. 30.
    Fodde R, Brabletz T (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19:150–158PubMedCrossRefGoogle Scholar
  31. 31.
    D’Mello SR, Anelli R, Calissano P (1994) Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp Cell Res 211:332–338PubMedCrossRefGoogle Scholar
  32. 32.
    Madiehe AM, Mampuru LJ, Tyobeka EM (1995) Induction of apoptosis in HL-60 cells by lithium. Biochem Biophys Res Commun 209:768–774PubMedCrossRefGoogle Scholar
  33. 33.
    Strovel ET, Sussman DJ (1999) Transient overexpression of murine dishevelled genes results in apoptotic cell death. Exp Cell Res 253:637–648PubMedCrossRefGoogle Scholar
  34. 34.
    Eischen CM, Woo D, Roussel MF, Cleveland JL (2001) Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol 21:5063–5070PubMedCrossRefGoogle Scholar
  35. 35.
    Wang C, Tai Y, Lisanti MP, Liao DJ (2011) c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis. Cancer Biol Ther 11:615–626PubMedCrossRefGoogle Scholar
  36. 36.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL (2001) Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F–1. Oncogene 20:6983–6993PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Yejing Zhu
    • 1
  • Jinyu Chi
    • 1
  • Yue Liu
    • 1
  • Yihua Sun
    • 2
  • Yu Fu
    • 1
  • Xiaohui Zhang
    • 1
  • Xueliang Ding
    • 1
  • Xinhua Yin
    • 1
  • Dechao Zhao
    • 1
  1. 1.Department of CardiologyThe First Affiliated Hospital of Harbin Medical UniversityHarbinPeople’s Republic of China
  2. 2.Department of Clinical LaboratoryThe Second Affiliated Hospital of Harbin Medical UniversityHarbinPeople’s Republic of China

Personalised recommendations